How to Submit to bioRxiv or medRxiv: A Submission Walkthrough

To submit to bioRxiv or medRxiv, register a free account, upload the manuscript and metadata, choose a license, and submit for two-step screening — staff review plus an automated plagiarism check — before the preprint posts with a Crossref DOI. If you have not chosen between the two servers yet, see How to Choose a Preprint Server first.

What is bioRxiv?

bioRxiv (pronounced “bio-archive”) is a free, open-access preprint server for the life sciences, covering subject areas from molecular biology and genetics to neuroscience, ecology, and synthetic biology. Cold Spring Harbor Laboratory (CSHL) launched it in November 2013; since March 2025 it has been operated by openRxiv, a nonprofit formed for that purpose, together with its sister site for health-sciences research, medRxiv. Their submission systems, screening policies, and license menus run on shared openRxiv infrastructure, which is why the mechanics below are close to identical between the two — the differences that matter are called out separately. Posting to either server is not a substitute for peer review: once a submission clears screening (see below), it receives a Crossref DOI (with a 10.1101 prefix) and becomes a permanent, citable record that is not removed even after the same work is later published in a peer-reviewed journal.

What both servers require before you submit

• The work must be unpublished at the time of submission and concern a relevant scientific or health field.
• Every author must have consented to the posting. There’s no requirement that all authors register accounts, but the submitting author is attesting on their behalf.
• Article type matters. Original research manuscripts (complete or in draft form) are acceptable. Narrative reviews, commentaries, opinion pieces, and step-by-step protocols are not — those categories are explicitly excluded during screening, not just discouraged.
• medRxiv layers on ICMJE-aligned requirements specific to clinical and health research: author names, affiliations, and contact information; a funding and competing-interests statement; a statement of IRB/research ethics committee approval (or an explanation of why it doesn’t apply); trial registration details where applicable; a data availability statement; and, where a relevant EQUATOR Network reporting checklist exists (CONSORT, STROBE, PRISMA, etc.), completion of it.

The submission process, step by step

In practice, getting a manuscript onto either server looks like this:

1. Register an account on biorxiv.org or medrxiv.org — free, no institutional gatekeeping beyond the content screening described below.
2. Prepare the manuscript file. The simplest route is a single PDF containing the full text plus figures and tables. Alternatively, upload a Word (or WordPerfect) file for the main text and tables, with figures as separate files — an automated conversion engine assembles these into a single PDF. Figure formats accepted include TIFF, EPS, and JPEG; PICT, Bitmap, Excel, and PSD files are not usable. LaTeX/TeX source must be converted to PDF before upload — neither server accepts raw TeX.
3. Add supplementary material separately (additional tables, extended data, video) rather than folding it into the main manuscript file.
4. Enter metadata: title, abstract, full author list with affiliations, corresponding-author contact details, funding sources, and a competing-interests declaration. Linking an ORCID iD for each author is supported and worth doing — it’s what lets the eventual preprint (and later, the published version of record) populate a researcher’s ORCID record automatically rather than requiring manual entry.
5. Choose a license (see below) and submit.

Screening and moderation: what happens after you click submit

Neither bioRxiv nor medRxiv performs peer review. What they do run, on every submission, is a two-step screening process:

• In-house staff screening checks that submission details are complete, confirms the manuscript is within scope, and confirms it’s an acceptable article type (see above).
• Automated text analysis checks for plagiarism and material that has already appeared online elsewhere.

All submissions are also screened for offensive or non-scientific content and for material that could pose a health or biosecurity risk. medRxiv’s screening goes further, specifically because it covers health research: submissions are checked for content that could endanger the health of individual patients or the public, including studies describing dual-use research of concern, or work that challenges accepted public health guidance on infectious disease transmission, immunization, or therapy. Affiliate screeners can escalate a submission to medRxiv’s in-house Content Team at any stage if they have concerns, and every medRxiv preprint carries a standing notice that it should not be used to guide clinical practice or health-related behavior, or reported in news media as established fact — screening filters out the most serious problems, but it is not a substitute for peer review, and the server says so directly on every page.

This screening/moderation role — real, but bounded to plagiarism, scope, and safety rather than scientific validity — is broadly consistent with COPE (Committee on Publication Ethics)‘s general guidance that preprint-server screening is not, and should not be presented as, peer review.

Licensing choices at submission

Both servers offer authors a license menu at submission — from most to least permissive:

• CC BY — reuse, remix, and redistribution permitted for any purpose, with attribution.
• CC BY-NC — reuse permitted with attribution, non-commercial purposes only.
• CC BY-ND — redistribution permitted with attribution, but the work can’t be altered or remixed without the corresponding author’s permission.
• CC BY-NC-ND — the most restrictive Creative Commons option offered: attribution required, no commercial use, no derivatives.
• No license (all rights reserved) — the default if nothing more permissive is selected; no reuse permission is granted at all.

Note that CC0 (public-domain dedication) is not part of bioRxiv’s license menu, unlike some other preprint servers (OSF Preprints, for instance). If a funder mandate requires a specific reuse license — most commonly CC BY, per cOAlition S/Plan S-aligned policies — check that requirement before submitting rather than after. As of a January 2026 policy update, bioRxiv authors can also change a posted preprint’s license after the fact (without filing a new version) provided the preprint is under two years old and the change moves to a less restrictive license, not a more restrictive one — Creative Commons licenses are irrevocable once applied, so tightening a license retroactively isn’t offered as an option. See Creative Commons Licenses for Research Data for a fuller comparison of what each license actually permits.

DOIs and revisions after posting

A DOI is assigned automatically when a preprint clears screening and posts — both servers register these via Crossref’s posted-content type. If you need to revise the manuscript later (correcting an error, adding data, responding to informal feedback), submitting a revision through the Author Area creates a new version (v2, v3, etc.) under the same DOI; earlier versions stay accessible rather than being overwritten, and a specific version can still be cited via its version-specific URL. You can post a revision at any point before the paper is accepted at a journal.

From preprint to journal: how the two relate

Posting to bioRxiv or medRxiv is not a substitute for peer review, and it’s not a competing publication event either. The ICMJE’s Recommendations are explicit that a preprint does not count as prior publication that would bar a journal from later considering the same work — the relevant clause states this “does not prevent a journal from considering a complete report that follows publication of a preliminary report, such as a letter to the editor, a preprint or an abstract or poster displayed at a scientific meeting.” ICMJE does put the disclosure burden on authors: you’re expected to tell the journal your work has been posted as a preprint, link to it, and note whether the posting happened before submission or during peer review.

Many journals have gone further than tolerating preprints — a substantial number now accept direct transfer from a preprint server as a submission route. bioRxiv operates a “B2J” (bioRxiv-to-journal) transfer pipeline: once a preprint is posted, an author can send its files and metadata directly into a participating journal’s or peer-review service’s submission queue with a few clicks, rather than re-uploading everything from scratch at the journal’s own site. Around 200 journals and portable peer-review services (including Review Commons) currently participate. Once a paper is accepted and published, good practice — and most journal instructions to authors — expect the preprint record to be updated to point to the published version of record, distinguishing it from the earlier author accepted manuscript stage. See How to Find, Look Up, and Resolve a DOI for how that preprint-to-published-version link is actually represented in DOI metadata.

One practical caveat worth checking before you post rather than after: a small number of journals in some fields (mainly clinical/orthopaedic specialties) still decline manuscripts previously posted to a preprint server, as a matter of their own editorial policy rather than any ICMJE requirement. It’s uncommon, but it’s real — confirm your target journal’s stated preprint policy if you already know where you intend to submit.

Frequently asked questions

Is there a fee to submit to bioRxiv or medRxiv?

No. Registration and article deposition are free on both platforms.

Do bioRxiv and medRxiv peer-review submissions?

No. Both run screening — checking scope, completeness, plagiarism, and (for medRxiv) health/biosecurity risk — but screening is explicitly not peer review, and neither platform claims otherwise.

Can I withdraw or retract a posted preprint?

Both platforms support withdrawing a preprint if a serious problem is found, though the original record typically remains visible with a note explaining the withdrawal, rather than disappearing entirely — this mirrors how a journal retraction works for published articles, preserving the scholarly record rather than erasing it.

Does posting a preprint stop me from submitting to a journal later?

No, per ICMJE’s own recommendations (quoted above) — preprints are not treated as prior publication. Check your target journal’s specific instructions to authors anyway; the overwhelming majority explicitly permit or actively encourage prior preprint posting, but policies do vary by journal and field.

What’s the difference between a preprint’s DOI and its eventual published DOI?

They’re two separate, permanently linked DOIs — the preprint keeps its own Crossref posted-content DOI even after the paper is published elsewhere, and Crossref’s metadata connects the two records so each links to the other. Neither server deletes or redirects the preprint once a published version exists.